Drug-Gene Testing: Key to Safer Cancer Treatment

Although the healthcare industry has a long way to go before PGx testing for DPYD and other genes becomes widespread, it’s encouraging that regulatory bodies and professional organizations are making recommendations and raising awareness among healthcare providers. The post Drug-Gene Testing: Key to Safer Cancer Treatment appeared first on MedCity News.

Read More

How Are Hospitals Bracing for Tariffs?

The Trump administration’s steep tariffs on Chinese imports are threatening to further destabilize hospitals’ bottom lines by driving up the cost of essential supplies and exacerbating already fragile supply chains. As providers prepare for higher expenses and potential shortages, experts warn that these policies could wosen care quality and force hospitals to make tough financial…

Read More

Why One Healthcare Founder Never Took Venture Capital

Randy Bolyga, founder CEO of RXNT, built his medical software company without venture capital, relying instead on SBA loans and a conservative, cash-positive growth strategy. He believes many venture capital-backed healthcare startups fail because they chase rapid growth without sustainable business models or a deep understanding of the market. The post Why One Healthcare Founder…

Read More

Medical Device Right to Repair is the Wrong Approach

How can physicians and patients be confident enough that vendors entirely ignorant of the FDA process for repair and reporting can properly recalibrate life-saving machines? Is this really the right place to argue that “anyone can do it?” The post Medical Device Right to Repair is the Wrong Approach appeared first on MedCity News.

Read More

When Patients Win,  Everyone Wins

When was the last time you asked a patient to contribute to trial design? Have you ever asked a patient to contribute to a protocol? Patient-centricity benefits the entire healthcare ecosystem. The post When Patients Win,  Everyone Wins appeared first on MedCity News.

Read More